EPRXF
Price:
$3.04
Market Cap:
$208.69M
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treating canine and equine osteoarthritis. Its products in development also include EP-201, an antibiotic for post-surgical site infections; and EP-105, an extended-release post-surgical anesthetic for post-surgical pain. In addition, the company develops product candidates for oncology. The company was formerly known as ...[Read more]
Industry
Biotechnology
IPO Date
2021-08-03
Stock Exchange
OTC
Ticker
EPRXF
According to Eupraxia Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 188.96M. This represents a change of 59.85% compared to the average of 118.21M of the last 4 quarters.
The mean historical Enterprise Value of Eupraxia Pharmaceuticals Inc. over the last ten years is 80.65M. The current 188.96M Enterprise Value has changed 23.33% with respect to the historical average. Over the past ten years (40 quarters), EPRXF's Enterprise Value was at its highest in in the June 2025 quarter at 187.07M. The Enterprise Value was at its lowest in in the September 2019 quarter at 0.
Average
80.65M
Median
88.27M
Minimum
23.56M
Maximum
114.61M
Discovering the peaks and valleys of Eupraxia Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 138.56%
Maximum Annual Enterprise Value = 114.61M
Minimum Annual Increase = -76.76%
Minimum Annual Enterprise Value = 23.56M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 73.34M | -36.01% |
| 2023 | 114.61M | 103.93% |
| 2022 | 56.20M | 138.56% |
| 2021 | 23.56M | -76.76% |
| 2020 | 101.39M | 1.85% |
| 2019 | 99.55M | 8.51% |
| 2018 | 91.74M | 8.19% |
The current Enterprise Value of Eupraxia Pharmaceuticals Inc. (EPRXF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
81.38M
5-year avg
73.82M
10-year avg
80.65M
Eupraxia Pharmaceuticals Inc.’s Enterprise Value is greater than Adocia S.A. (140.62M), less than Prescient Therapeutics Limited (0), greater than BioHarvest Sciences Inc. (110.68M), less than Anteris Technologies Ltd (189.59M), less than Ascentage Pharma Group International (20.23B), greater than Mind Cure Health Inc. (111.38M), greater than Leafly Holdings, Inc. (132.00M), greater than E-therapeutics Plc (36.91M), less than Lee's Pharmaceutical Holdings Limited (929.29M), greater than Herantis Pharma Oyj (51.38M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 140.62M | $103.66M | |
| 0 | $117.53M | |
| 110.68M | $109.16M | |
| 189.59M | $120.50M | |
| 20.23B | $127.31M | |
| 111.38M | $86.53M | |
| 132.00M | $114.90M | |
| 36.91M | $75.96M | |
| 929.29M | $112.06M | |
| 51.38M | $59.47M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eupraxia Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eupraxia Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Eupraxia Pharmaceuticals Inc.'s Enterprise Value?
What is the highest Enterprise Value for Eupraxia Pharmaceuticals Inc. (EPRXF)?
What is the 3-year average Enterprise Value for Eupraxia Pharmaceuticals Inc. (EPRXF)?
What is the 5-year average Enterprise Value for Eupraxia Pharmaceuticals Inc. (EPRXF)?
How does the current Enterprise Value for Eupraxia Pharmaceuticals Inc. (EPRXF) compare to its historical average?